Ani Pharmaceuticals Inc (ANIP)
CIK 1023024 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ani Pharmaceuticals Inc.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 11, 2026 | 144 | 0001950047-26-009361 |
| Sep 1, 2026 | 4 | 0001674236-26-000022 |
| Aug 27, 2026 | 4 | 0001659625-26-000011 |
| Aug 27, 2026 | 3 | 0001659625-26-000010 |
| Aug 26, 2026 | 4 | 0001822629-26-000014 |
| Aug 25, 2026 | 144 | 0001950047-26-008689 |
| Aug 24, 2026 | 8-K | 0001023024-26-000071 |
| Aug 13, 2026 | 4 | 0001938861-26-000023 |
| Aug 11, 2026 | 4 | 0001846478-26-000015 |
| Aug 7, 2026 | 8-K | 0001023024-26-000068 |
| Aug 7, 2026 | 10-Q | 0001023024-26-000069 |
| Jul 30, 2026 | 4 | 0001674236-26-000019 |
| Jul 29, 2026 | 144 | 0001950047-26-007411 |
| Jul 27, 2026 | SCHEDULE 13G/A | 0002012383-26-002156 |
| Jul 21, 2026 | 4 | 0001938861-26-000021 |
| Jul 17, 2026 | S-8 | 0001023024-26-000059 |
| Jul 14, 2026 | 4 | 0001938861-26-000019 |
| Jul 7, 2026 | 144 | 0001950047-26-006912 |
| Jul 6, 2026 | 4 | 0001674236-26-000017 |
| Jun 30, 2026 | 4 | 0001674236-26-000015 |
| Jun 15, 2026 | 4 | 0001938861-26-000017 |
| Jun 10, 2026 | 4 | 0001773152-26-000003 |
| Jun 10, 2026 | 4 | 0001272247-26-000004 |
| Jun 10, 2026 | 4 | 0001819879-26-000003 |
| Jun 10, 2026 | 4 | 0001543174-26-000003 |